https://www.coltonconsortium.org/news/yale-researchers-use-machine-learning-to-improve-personalized-cancer-vaccine-design/
A Colton-supported Yale study has produced ImmunoStruct, a machine learning model that improves personalized cancer vaccine design by incorporating the 3D structure of immune-activating peptides — now licensed to a Yale spinout.
https://www.coltonconsortium.org/news/a-new-research-hub-for-autoimmunity-and-immune-health-at-penn-medicine/
Penn Medicine has opened a new research facility housing the Colton Center for Autoimmunity alongside immune health, vaccinology, and infectious disease teams — designed to accelerate breakthrough science through collaboration.
https://www.coltonconsortium.org/news/yales-colton-center-for-autoimmunity-awards-nearly-1m-to-nine-research-projects-in-2025/
Yale's Colton Center for Autoimmunity has selected nine researchers for nearly $1 million in 2025 funding, backing projects that apply AI, nanoparticles, and novel biologics to autoimmune disease.
https://www.coltonconsortium.org/news/inside-the-2025-colton-consortium-symposium-driving-translational-research-in-autoimmune-disease/
Global leaders in autoimmune research gathered for the 2025 Colton Consortium Symposium last month, sharing breakthroughs from foundational science to translational therapies and forging collaborations to improve patient lives worldwide.
https://www.coltonconsortium.org/news/penn-colton-center-launches-two-new-centers-of-excellence-to-fast-track-autoimmune-treatments/
The Penn Colton Center has launched two new Centers of Excellence — HIT-AI, focused on AI-driven drug repurposing, and CREATE, pioneering mRNA therapies — to accelerate next-generation autoimmune diagnostics and treatments.
https://www.coltonconsortium.org/news/building-the-future-of-immune-health-highlights-from-the-2025-penn-colton-center-symposium/
The 2025 Penn Colton Center Symposium convened 150+ experts to explore breakthroughs in immune health and spotlight Penn's leadership, future headquarters, and innovations in autoimmunity research and precision medicine.
https://www.coltonconsortium.org/news/new-hope-for-sjgrens-disease-patients-nyu-study-links-calcium-signaling-and-t-cell-dysfunction-to-the-condition/
A Colton-supported NYU study published in Science Translational Medicine has identified impaired regulatory T cells as a key driver of Sjögren's disease — and found a promising existing drug as a potential therapy.
https://www.coltonconsortium.org/news/yales-colton-center-for-autoimmunity-funds-11-research-projects-in-2024/
Yale's Colton Center for Autoimmunity has selected eleven faculty-led projects for 2024 funding, supporting breakthrough research into lupus, asthma, allergies, and other autoimmune diseases — with mentorship and commercialization support included.
https://www.coltonconsortium.org/news/tau-colton-centers-2024-grant-recipients-tackle-autoimmune-disease-across-nine-interdisciplinary-projects/
Tel Aviv University's Colton Center has awarded nine interdisciplinary research grants in 2024, funding projects that explore autoimmune disease from organ-on-a-chip platforms to the role of stress and psychological factors in disease flare-ups.
https://www.coltonconsortium.org/news/tel-aviv-university-opens-israels-first-autoimmune-disease-research-center/
Tel Aviv University's Colton Center for Autoimmunity joins a four-university consortium dedicated to finding cures for over 100 autoimmune diseases through big data analytics, multidisciplinary research, and international collaboration.